🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-institution, open-label, Phase 1b/2 clinical trial ev...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2021-03-30
Trial ID
NCT04798339
Treatments Being Tested
This single arm study will assess the efficacy, safety and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00882713
Treatments Being Tested
In chronic kidney disease, ESAs (Erythropoiesis-stimulating agents) are use...
Status
Completed
Location
CHU de Rennes
Start Date
2018-09-21
Trial ID
NCT03481686
Treatments Being Tested
This study was conducted to explore a new therapy for anemia in participant...
Status
Completed
Location
Site BE32004
Start Date
2014-11-21
Trial ID
NCT02278341
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacodynamics (PD),...
Status
Completed
Location
Research Facility
Start Date
2005-07
Trial ID
NCT00228449
Treatments Being Tested
The purpose of this study was to evaluate the safety and efficacy of pegine...
Status
Completed
Location
Research Facility
Start Date
2007-10
Trial ID
NCT00597584
Treatments Being Tested
This is a phase III, randomized, open-label, active-controlled study to eva...
Status
Recruiting
Location
Fudan Univeristy Zhongshan Hospital
Start Date
2025-10-31
Trial ID
NCT07494409
Treatments Being Tested
BCD-131 is pegylated darbepoetin beta. This clinical study BCD-131-3 is a r...
Status
Recruiting
Location
Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology
Start Date
2025-03-01
Trial ID
NCT07119372
Treatments Being Tested
The purpose of this study was to evaluate the long term safety and tolerabi...
Status
Terminated
Location
Research Facility
Start Date
2006-11
Trial ID
NCT00453973
Treatments Being Tested
This is a Phase III, randomized, open-label, active-controlled study to eva...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-12-03
Trial ID
NCT07487727